The International Working Group on the Diabetic Foot (IWGDF) has unveiled 2023 guidelines which now includes topical oxygen therapy as a positive adjunctive treatment recommendation.
The announcement, which occurred at the International Symposium on the Diabetic Foot (ISDF), puts the therapy in line with positive sentiment by the American Diabetes Association (ADA).
Oxygen therapy product developers such as AOTI will benefit from the recommendation. AOTI’s therapy uses cyclical pressurised oxygen that can be applied directly to a wound site. Amongst other indications – such as venous leg ulcers, burn wounds and pressure ulcers – diabetic foot ulcers (DFU) are a key chronic wound use of the products. Oxygen promotes faster and more durable healing, whilst compression reduces oedema and enhances vascular circulation.
